Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech

MigreLief Now On Lifetime T.V.’s “The Balancing Act” Airing June 20th & July 25th

June 14, 2011 By Bio-Medicine.Org

LOS ANGELES, June 14, 2011 /PRNewswire/ — The makers of MigreLief, the world’s most
successful patented natural migraine prevention therapy, can now be
seen on the popular nationally broadcast Lifetime series, “The
Balancing Act.”
On June 20th and again on July 25th, (7:00
a.m. et/pt)
this informative and entertaining show that
provides a daily source of tips, knowledge and latest health news
for women, will feature the first name in migraine relief,
MigreLief.

Being interviewed on “The Balancing Act,” MigreLief
developer, Curt Hendrix, M.S., C.C.N., C.N.S., explains, “MigreLief
was designed to correct deficiencies and imbalances, help the body
heal itself and prevent migraines. Its goal is to stop migraines
from ever happening in the first place.”

MigreLief is the only multi-patented, physician recommended
nutritional supplement for either men, women or children who suffer
from chronic migraine headaches. It contains ingredients proven to
decrease both the number and intensity of migraines.

MigreLief comes in 3 formulas: Original formula for men, women
and children over the age of 12, MigreLief+M, a menstrual formula
for women who suffer from menstrual related migraines and PMS, and
Children’s MigreLief for children under the age of 12.

Recurring migraines and running the gambit of side-effect prone
prescription and OTC drugs is a lifestyle for many migraineurs
seeking relief. First publicly available in 1997 as a
non-prescription preventive therapy, MigreLief has restored quality
of life to migraine sufferers worldwide and has been recommended by
neurologists and headache specialists as an alternative and
complimentary therapy.

MigreLief’s “Triple-Therapy” approach to migraine prevention is
based on three ingredients listed in the American Academy of
Neurology’s Evidence Based Guidelines for Migraine Prophylaxis;
magnesium (oxide/citrate), high dose riboflavin (B

‘/>”/>

SOURCE

Related Articles Read More >

Blackrock's Utah array is a miniature array of electrodes for sensing brain signals
Blackrock Neurotech and Pitt work on first at-home BCI system for remote trials
DeepWell Digital Therapeutics Mike Wilson Ryan Douglas
How DeepWell is developing video games as tools for treating medical conditions
A woman with a small, handheld device in her lap with tubes that look like earphones plugged into her ears.
Ear-puffing device for migraine treatment wins FDA breakthrough designation
Abbott
Abbott launches upgraded digital health app for neurostimulation

DeviceTalks Weekly.

June 24, 2022
How innovative design, commercial strategy is building Cala Trio’s bioelectronic medicine market
See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

Enewsletter Subscriptions

Enewsletter Subscriptions

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech 100 Index
  • Medical Tubing + Extrusion
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to E-newsletter
  • Attend our Monthly Webinars
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2022 WTWH Media, LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media LLC. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech